Date Title and Summary Additional Formats
Apr 17, 2023
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
Apr 12, 2023
 Monthly information related to total number of voting rights and shares composing the share capital _March 31, 2023
Mar 22, 2023
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
Mar 06, 2023
Monthly information related to total number of voting rights and shares composing the share capital _February 28, 2023
Feb 15, 2023
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies
Feb 09, 2023
Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023
Jan 09, 2023
Monthly information related to total number of voting rights and shares composing the share capital _December 31, 2022